These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8928539)

  • 41. Renin producing neuroendocrine pancreatic carcinoma--a case report and review of the literature.
    Langer P; Bartsch D; Gerdes B; Schwetlick I; Wild A; Brehm B; Erley C; Lamberts R
    Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):43-9. PubMed ID: 11835125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful treatment of a patient with octreotide-resistant necrolytic migratory erythema.
    Bewley AP; Ross JS; Bunker CB; Staughton RC
    Br J Dermatol; 1996 Jun; 134(6):1101-4. PubMed ID: 8763433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Octreotide in control of multiple liver metastases from gastrinoma.
    Saijo F; Naito H; Funayama Y; Fukushima K; Shibata C; Hashimoto A; Kitayama T; Nagao M; Matsuno S; Sasaki I
    J Gastroenterol; 2003; 38(9):905-8. PubMed ID: 14564638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glucagonoma syndrome.
    Bloom SR; Polak JM
    Am J Med; 1987 May; 82(5B):25-36. PubMed ID: 2884877
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improvement of metastatic endocrine tumors of the pancreas by hepatic artery chemoembolization.
    Nesović M; Cirić J; Radojković S; Zarković M; Durović M
    J Endocrinol Invest; 1992; 15(7):543-7. PubMed ID: 1447492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Glucagonoma--somatostatinoma].
    Schusdziarra V
    Z Gastroenterol; 1999 Jun; Suppl 1():33-5. PubMed ID: 10444813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glucagonoma-associated neuropsychiatric and affective symptoms: diagnostic dilemmas raised by paraneoplastic phenomena.
    McGevna L; McFadden D; Ritvo J; Rabinowitz T
    Psychosomatics; 2009; 50(5):548-50. PubMed ID: 19855043
    [No Abstract]   [Full Text] [Related]  

  • 48. [Glucagonoma. A tumor disease with multiple clinical manifestations].
    Andersson K; Wängberg B; Tisell LE; Nilsson O; Fjälling M; Forssell-Aronsson E; Ahrén B; Ahlman H
    Lakartidningen; 1996 Aug; 93(35):2935-9. PubMed ID: 8815353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolonged survival after resection of pancreatoblastoma and synchronous liver metastases in an adult.
    Benoist S; Penna C; Julié C; Malafosse R; Rougier P; Nordlinger B
    Hepatogastroenterology; 2001; 48(41):1340-2. PubMed ID: 11677959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Laparoscopic resection for nonfunctioning small glucagon-producing tumor: report of a case and review of the literature.
    Yada K; Hirano S; Himeno Y; Shibata K; Matsumoto T; Aramaki M; Kawano K; Kitano S
    J Hepatobiliary Pancreat Surg; 2003; 10(5):382-5. PubMed ID: 14598140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amino acid, glucose, and lipid kinetics after palliative resection in a patient with glucagonoma syndrome.
    Bernstein M; Jahoor F; Townsend CM; Klein S
    Metabolism; 2001 Jun; 50(6):720-2. PubMed ID: 11398151
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metastatic pancreatic VIPoma: deteriorating clinical course and successful treatment by liver transplantation.
    Hengst K; Nashan B; Avenhaus W; Ullerich H; Schlitt HJ; Flemming P; Pichlmayr R; Domschke W
    Z Gastroenterol; 1998 Mar; 36(3):239-45. PubMed ID: 9577908
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The glucagonomas (author's transl)].
    Luyckx AS; Lefebvre PJ
    Diabete Metab; 1981 Dec; 7(4):289-300. PubMed ID: 6120860
    [No Abstract]   [Full Text] [Related]  

  • 54. [Chemoembolization followed by systemic chemotherapy with dacarbazine for a metastatic glucagonoma].
    D'Alteroche L; Viguier J; Maillard H; Debbabi S; Certin M; Metman EH
    Gastroenterol Clin Biol; 2000 Jan; 24(1):132-3. PubMed ID: 10755862
    [No Abstract]   [Full Text] [Related]  

  • 55. [Rare pancreatic endocrine tumors].
    Krysiak R; Okopień B; Herman ZS
    Przegl Lek; 2008; 65(4):209-16. PubMed ID: 18724549
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surgical experience with functioning pancreatic neuroendocrine tumors.
    Matthews BD; Smith TI; Kercher KW; Holder WD; Heniford BT
    Am Surg; 2002 Aug; 68(8):660-5; discussion 665-6. PubMed ID: 12206598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Efficacy of somatostatin analogs in the treatment of neuroendocrine tumours and paraneoplastic syndromes].
    Sperlongano P; De Falco M; Pisaniello D; Parmeggiani D; Parmeggiani U
    Minerva Endocrinol; 2001 Dec; 26(4):293-5. PubMed ID: 11782719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A case of HCC with inferior caval vein tumor thrombus and multiple pulmonary metastases that remarkably responded to combination therapy of TS-1 and interferon-alpha].
    Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Yoshioka S; Kato H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1824-8. PubMed ID: 16315953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma.
    Technau K; Renkl A; Norgauer J; Ziemer M
    Eur J Dermatol; 2005; 15(2):110-2. PubMed ID: 15757825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medical treatment of endocrine gastroenteropancreatic tumors.
    Tomassetti P; Campana D; Nori F; Piscitelli L; Salomone L; Pezzilli R; Corinaldesi R
    JOP; 2006 Jan; 7(1):145-9. PubMed ID: 16407637
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.